Safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity
Safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity
复制标题
同时进行双侧 25 号晶状体保留玻璃体切除术治疗血管活动性 4 期早产儿视网膜病变的安全性和有效性
作者：
P. Shah;V. Narendran;N. Kalpana
目的报告同期双眼保留晶状体的玻璃体切割术治疗血管活动性早产儿4期视网膜病变(ROP)的安全性和有效性。双眼血管活跃的4期ROP婴儿10只眼20只眼同时接受了保留晶状体的双眼玻璃体切割术。在完成一只眼睛的手术后，另一只眼睛在开始任何不同患者的新病例之前重新准备，并使用了一整套新的一次性25号器械。在术后一段时间内，建议父母每只眼分别滴眼液，并在换眼期间洗手。结果平均随访8.7个月(4~17个月)。所有病例均未出现任何感染迹象。4a期的解剖成功率为100%(11/11眼)，4b期的解剖成功率为8/9眼(89%)。结论同期行双眼保留晶状体的玻璃体切割术治疗4期ROP是一种安全、有效、效果良好的手术方法，只要将婴儿的双眼当作两个不同患者的眼睛处理即可。
PurposeTo report the safety and efficacy of simultaneous bilateral 25-gauge lens-sparing vitrectomy for vascularly active stage 4 retinopathy of prematurity (ROP).MethodsRetrospective, noncomparative, consecutive case series. Twenty eyes of 10 babies who presented with vascularly active stage 4 ROP in both the eyes underwent simultaneous bilateral 25-gauge lens-sparing vitrectomy. After completing surgery for one eye, the other eye was re-prepped as performed before starting any new case of a different patient and an entire new set of disposable 25-gauge instruments were used. During the post-operative period parents were advised to keep separate eye drops for each eye and to wash their hands in between switching the eyes to put the drops.ResultsThe mean follow-up was 8.7 months (range 4–17 months). None of the cases developed any signs of infection. The anatomic success rate for stage 4a was 100% (11/11 eyes) and for stage 4b was 8/9 eyes (89%).ConclusionThese results show that simultaneous bilateral 25-gauge lens-sparing vitrectomy for stage 4 ROP is a safe and effective procedure with a good outcome provided both eyes of the baby are treated as eyes of two different patients.
影响因子：
--
作者：
W. Tasman
通讯作者：
W. Tasman